US Stock MarketDetailed Quotes

Sensus Healthcare (SRTS)

Watchlist
  • 4.490
  • +0.050+1.13%
Close Apr 17 15:59 ET
  • 4.490
  • 0.0000.00%
Post 16:04 ET
73.91MMarket Cap-9.55P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sensus Healthcare (SRTS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
163.54%528K
-166.87%-2.21M
-41.94%2.3M
-26.31%3.12M
67.30%-2.68M
61.26%-831K
-131.00%-827K
794.34%3.95M
470.08%4.23M
-36.52%-8.19M
Net income from continuing operations
-216.13%-7.72M
-304.85%-3.17M
-177.61%-943K
-164.33%-1.04M
-213.10%-2.57M
1,270.52%6.65M
-63.28%1.55M
183.74%1.22M
524.21%1.61M
220.06%2.27M
Depreciation and amortization
44.91%626K
22.39%164K
55.88%159K
102.56%158K
22.88%145K
-6.29%432K
26.42%134K
-3.77%102K
-39.06%78K
-2.48%118K
Deferred tax
-3,201.75%-1.88M
--158K
-158.05%-1.43M
-118.43%-723K
-86.70%110K
86.65%-57K
--0
-342.40%-553K
33.93%-331K
203.12%827K
Change In working capital
201.25%8.66M
116.59%465K
30.08%4.12M
67.12%4.56M
95.84%-484K
-140.28%-8.55M
5.91%-2.8M
72.08%3.17M
108.88%2.73M
-212.42%-11.65M
-Change in receivables
248.18%13.65M
218.95%3.3M
159.15%3.24M
318.29%5.4M
119.08%1.71M
-238.54%-9.21M
26.37%-2.77M
-44.74%1.25M
-63.96%1.29M
-296.67%-8.98M
-Change in inventory
-1,829.48%-4.64M
-181.81%-922K
-431.48%-537K
-240.46%-2.59M
79.55%-586K
103.12%268K
-9.19%1.13M
105.10%162K
148.67%1.84M
-0.35%-2.87M
-Change in prepaid assets
605.54%1.83M
88.85%-181K
-16.77%1.34M
778.40%2.97M
-236.20%-2.3M
-111.02%-361K
-269.17%-1.62M
-41.33%1.61M
-88.51%338K
79.67%-685K
-Change in payables and accrued expense
-174.10%-1.47M
-371.60%-2.28M
-63.13%254K
40.79%-270K
-9.45%824K
155.32%1.98M
171.69%838K
1,087.93%689K
53.80%-456K
161.36%910K
-Change in other current assets
64.88%-164K
1,862.96%530K
107.29%31K
-865.63%-735K
106.06%10K
13.52%-467K
157.45%27K
-533.67%-425K
134.66%96K
47.45%-165K
-Change in other current liabilities
-33.70%-242K
-28.57%-63K
-29.79%-61K
-28.26%-59K
-51.28%-59K
9.95%-181K
0.00%-49K
2.08%-47K
20.69%-46K
15.22%-39K
-Change in other working capital
48.55%-301K
123.30%82K
-105.56%-148K
55.03%-152K
-146.89%-83K
-0.34%-585K
-130.07%-352K
28.71%-72K
-228.16%-338K
178.32%177K
Cash from discontinued investing activities
Operating cash flow
163.54%528K
-166.87%-2.21M
-41.94%2.3M
-26.31%3.12M
67.30%-2.68M
61.26%-831K
-131.00%-827K
794.34%3.95M
470.08%4.23M
-36.52%-8.19M
Investing cash flow
Cash flow from continuing investing activities
28.99%-196K
-153.20%-158K
98.81%-4K
-800.00%-27K
97.00%-7K
-47.59%-276K
297K
-1,187.10%-337K
89.66%-3K
-23.28%-233K
Net PPE purchase and sale
28.99%-196K
-153.20%-158K
98.81%-4K
-800.00%-27K
97.00%-7K
-20.52%-276K
--297K
-2,963.64%-337K
89.66%-3K
-23.28%-233K
Cash from discontinued investing activities
Investing cash flow
28.99%-196K
-153.20%-158K
98.81%-4K
-800.00%-27K
97.00%-7K
-47.59%-276K
--297K
-1,187.10%-337K
89.66%-3K
-23.28%-233K
Financing cash flow
Cash flow from continuing financing activities
-2,133.33%-305K
-117.86%-5K
0
0
-300K
137.50%15K
500.00%28K
23.08%-30K
17K
0
Net common stock issuance
---300K
--0
--0
--0
---300K
--0
--47K
---47K
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--0
----
----
45.65%67K
--33K
--17K
--17K
--0
Net other financing activities
90.38%-5K
----
----
----
----
11.86%-52K
28.57%-5K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-2,133.33%-305K
-117.86%-5K
--0
--0
---300K
137.50%15K
500.00%28K
23.08%-30K
--17K
--0
Net cash flow
Beginning cash position
-4.72%22.06M
8.40%24.45M
16.81%22.16M
29.49%19.07M
-4.72%22.06M
-9.29%23.15M
10.11%22.56M
-5.39%18.97M
-23.85%14.73M
-9.29%23.15M
Current changes in cash
102.47%27K
-372.11%-2.37M
-36.11%2.29M
-27.19%3.09M
64.56%-2.98M
53.96%-1.09M
-118.87%-502K
726.27%3.59M
495.23%4.24M
-36.25%-8.42M
End cash Position
0.12%22.08M
0.12%22.08M
8.40%24.45M
16.81%22.16M
29.49%19.07M
-4.72%22.06M
-4.72%22.06M
10.11%22.56M
-5.39%18.97M
-23.85%14.73M
Free cash flow
129.99%332K
-346.23%-2.37M
-36.64%2.29M
-26.90%3.09M
68.12%-2.68M
53.37%-1.11M
-119.87%-530K
738.98%3.62M
492.85%4.23M
-36.11%-8.42M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 163.54%528K-166.87%-2.21M-41.94%2.3M-26.31%3.12M67.30%-2.68M61.26%-831K-131.00%-827K794.34%3.95M470.08%4.23M-36.52%-8.19M
Net income from continuing operations -216.13%-7.72M-304.85%-3.17M-177.61%-943K-164.33%-1.04M-213.10%-2.57M1,270.52%6.65M-63.28%1.55M183.74%1.22M524.21%1.61M220.06%2.27M
Depreciation and amortization 44.91%626K22.39%164K55.88%159K102.56%158K22.88%145K-6.29%432K26.42%134K-3.77%102K-39.06%78K-2.48%118K
Deferred tax -3,201.75%-1.88M--158K-158.05%-1.43M-118.43%-723K-86.70%110K86.65%-57K--0-342.40%-553K33.93%-331K203.12%827K
Change In working capital 201.25%8.66M116.59%465K30.08%4.12M67.12%4.56M95.84%-484K-140.28%-8.55M5.91%-2.8M72.08%3.17M108.88%2.73M-212.42%-11.65M
-Change in receivables 248.18%13.65M218.95%3.3M159.15%3.24M318.29%5.4M119.08%1.71M-238.54%-9.21M26.37%-2.77M-44.74%1.25M-63.96%1.29M-296.67%-8.98M
-Change in inventory -1,829.48%-4.64M-181.81%-922K-431.48%-537K-240.46%-2.59M79.55%-586K103.12%268K-9.19%1.13M105.10%162K148.67%1.84M-0.35%-2.87M
-Change in prepaid assets 605.54%1.83M88.85%-181K-16.77%1.34M778.40%2.97M-236.20%-2.3M-111.02%-361K-269.17%-1.62M-41.33%1.61M-88.51%338K79.67%-685K
-Change in payables and accrued expense -174.10%-1.47M-371.60%-2.28M-63.13%254K40.79%-270K-9.45%824K155.32%1.98M171.69%838K1,087.93%689K53.80%-456K161.36%910K
-Change in other current assets 64.88%-164K1,862.96%530K107.29%31K-865.63%-735K106.06%10K13.52%-467K157.45%27K-533.67%-425K134.66%96K47.45%-165K
-Change in other current liabilities -33.70%-242K-28.57%-63K-29.79%-61K-28.26%-59K-51.28%-59K9.95%-181K0.00%-49K2.08%-47K20.69%-46K15.22%-39K
-Change in other working capital 48.55%-301K123.30%82K-105.56%-148K55.03%-152K-146.89%-83K-0.34%-585K-130.07%-352K28.71%-72K-228.16%-338K178.32%177K
Cash from discontinued investing activities
Operating cash flow 163.54%528K-166.87%-2.21M-41.94%2.3M-26.31%3.12M67.30%-2.68M61.26%-831K-131.00%-827K794.34%3.95M470.08%4.23M-36.52%-8.19M
Investing cash flow
Cash flow from continuing investing activities 28.99%-196K-153.20%-158K98.81%-4K-800.00%-27K97.00%-7K-47.59%-276K297K-1,187.10%-337K89.66%-3K-23.28%-233K
Net PPE purchase and sale 28.99%-196K-153.20%-158K98.81%-4K-800.00%-27K97.00%-7K-20.52%-276K--297K-2,963.64%-337K89.66%-3K-23.28%-233K
Cash from discontinued investing activities
Investing cash flow 28.99%-196K-153.20%-158K98.81%-4K-800.00%-27K97.00%-7K-47.59%-276K--297K-1,187.10%-337K89.66%-3K-23.28%-233K
Financing cash flow
Cash flow from continuing financing activities -2,133.33%-305K-117.86%-5K00-300K137.50%15K500.00%28K23.08%-30K17K0
Net common stock issuance ---300K--0--0--0---300K--0--47K---47K--0--0
Proceeds from stock option exercised by employees --0--0--0--------45.65%67K--33K--17K--17K--0
Net other financing activities 90.38%-5K----------------11.86%-52K28.57%-5K------------
Cash from discontinued financing activities
Financing cash flow -2,133.33%-305K-117.86%-5K--0--0---300K137.50%15K500.00%28K23.08%-30K--17K--0
Net cash flow
Beginning cash position -4.72%22.06M8.40%24.45M16.81%22.16M29.49%19.07M-4.72%22.06M-9.29%23.15M10.11%22.56M-5.39%18.97M-23.85%14.73M-9.29%23.15M
Current changes in cash 102.47%27K-372.11%-2.37M-36.11%2.29M-27.19%3.09M64.56%-2.98M53.96%-1.09M-118.87%-502K726.27%3.59M495.23%4.24M-36.25%-8.42M
End cash Position 0.12%22.08M0.12%22.08M8.40%24.45M16.81%22.16M29.49%19.07M-4.72%22.06M-4.72%22.06M10.11%22.56M-5.39%18.97M-23.85%14.73M
Free cash flow 129.99%332K-346.23%-2.37M-36.64%2.29M-26.90%3.09M68.12%-2.68M53.37%-1.11M-119.87%-530K738.98%3.62M492.85%4.23M-36.11%-8.42M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -